01 6Gowling Lafleur Henderson LLP
02 125Merck Canada Inc.
03 10Schering-Plough Canada Inc.
01 51341567
02 22172664
03 102201749
04 22203480
05 102236591
06 102245938
07 102246162
08 102268433
09 112287056
10 102288038
11 112300452
12 142323849
13 102324467
14 102329474
15 22334267
16 142365412
01 10Interferon Alpha-2b | ribavirin
02 131Peginterferon alfa-2b | Ribavirin
01 10Capsules and Solution for Inj.
02 65Capsules plus Powder for Solution for Injection
03 48Powder for Solution for Injection plus Capsule
04 12Powder for Solution for Injection pus Capsule
05 3Solution ;Tablets
06 3Solution;Tablets
01 102015-10-10
02 22016-03-26
03 202016-10-31
04 102017-01-21
05 22017-04-23
06 102018-04-28
07 102018-08-26
08 102018-12-16
09 502018-12-21
10 102019-03-24
11 22019-05-29
12 52025-02-19
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : PEGASYS RBV
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 180 mcg / 0.5 mL; 200 mg
Dosage Form : Solution ;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Brand Name : PEGASYS RBV
Patent Number : 2172664
Filing Date : 1996-03-26
Strength per Unit : 180 mcg / mL / vial; 200 mg
Dosage Form : Solution;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2016-03-26
Date Granted : 2000-10-03
Patent Expiration Date : 2019-05-29
Date Granted : 2009-02-17
Brand Name : PEGASYS RBV
Patent Number : 2334267
Filing Date : 1999-05-29
Strength per Unit : 180 mcg / 0.5 mL; 200 mg
Dosage Form : Solution ;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2019-05-29
Date Granted : 2009-02-17
Patent Expiration Date : 2017-04-23
Date Granted : 2009-06-30
Brand Name : PEGASYS RBV
Patent Number : 2203480
Filing Date : 1997-04-23
Strength per Unit : 180 mcg / 0.5 mL; 200 mg
Dosage Form : Solution ;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2017-04-23
Date Granted : 2009-06-30
Patent Expiration Date : 2019-05-29
Date Granted : 2009-02-17
Brand Name : PEGASYS RBV
Patent Number : 2334267
Filing Date : 1999-05-29
Strength per Unit : 180 mcg / mL / vial; 200 mg
Dosage Form : Solution;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2019-05-29
Date Granted : 2009-02-17
Patent Expiration Date : 2017-04-23
Date Granted : 2009-06-30
Brand Name : PEGASYS RBV
Patent Number : 2203480
Filing Date : 1997-04-23
Strength per Unit : 180 mcg / mL / vial; 200 mg
Dosage Form : Solution;Tablets
Human Or VET : Human
Route of Administration : Subcutaneous and Oral
Patent Expiration Date : 2017-04-23
Date Granted : 2009-06-30
Patent Expiration Date : 2018-12-21
Date Granted : 2000-11-28
Brand Name : REBETRON
Patent Number : 2300452
Filing Date : 1998-12-21
Strength per Unit : 200mg/caps + 18MIU/pen
Dosage Form : Capsules and Solution for Inj.
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Inj.
Patent Expiration Date : 2018-12-21
Date Granted : 2000-11-28
Patent Expiration Date : 2018-12-21
Date Granted : 2002-06-11
Brand Name : REBETRON
Patent Number : 2323849
Filing Date : 1998-12-21
Strength per Unit : 200mg/caps + 18MIU/pen
Dosage Form : Capsules and Solution for Inj.
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Inj.
Patent Expiration Date : 2018-12-21
Date Granted : 2002-06-11
Patent Expiration Date : 2018-12-21
Date Granted : 2002-09-17
Brand Name : REBETRON
Patent Number : 2365412
Filing Date : 1998-12-21
Strength per Unit : 200mg/caps + 18MIU/pen
Dosage Form : Capsules and Solution for Inj.
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Inj.
Patent Expiration Date : 2018-12-21
Date Granted : 2002-09-17
Patent Expiration Date : 2018-12-21
Date Granted : 2000-08-15
Brand Name : REBETRON
Patent Number : 2287056
Filing Date : 1998-12-21
Strength per Unit : 200mg/caps + 18MIU/pen
Dosage Form : Capsules and Solution for Inj.
Human Or VET : Human
Route of Administration : Oral and Subcutaneous Inj.
Patent Expiration Date : 2018-12-21
Date Granted : 2000-08-15
